• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume10, Issue2

A Comparative Study of Efficacy of Atorvastatin and Atorvastatin with Omega-3 Fatty Acids Combination in Dyslipidemic Patients

    Dr. Sanjay Kumar, Asha Kumari, Rajesh Kumar Pandey, Naveen Kumar, Nuzhat Perween, Rajiv Ranjan .

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 2, Pages 1542-1547

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background and Objectives: Hyperlipidaemia refers to elevated levels of lipids in the blood. Lipids such as cholesterol and triglycerides are insoluble in plasma. Circulating lipid is carried in lipoproteins that transport the lipid to various tissues for energy use, lipid deposition, steroid hormone production, and bile acid formation. To compare the efficacy of Atorvastatin alone with Atorvastatin plus Omega- 3 fatty acids combination in management of hyperlipidaemia. Methods: The study was a comparative, prospective, randomized and open label study. Patients with history of recent MI or post MI, attending the out patients / in patients, Department of General Medicine, DMCH, Darbhanga. Study duration of Two years. Conclusion: The efficacy of combination therapy i.e., Atorvastatin plus Omega-3 fatty acids showed statistically significant rise in HDL cholesterol with mean percentage difference of 3.7% when compared to monotherapy with Atorvastatin.
Keywords:
    Hyperlipidaemia Atorvastatin HDL LDL VLDL
  • PDF (152 K)
  • XML
(2023). A Comparative Study of Efficacy of Atorvastatin and Atorvastatin with Omega-3 Fatty Acids Combination in Dyslipidemic Patients. European Journal of Molecular & Clinical Medicine, 10(2), 1542-1547.
Dr. Sanjay Kumar, Asha Kumari, Rajesh Kumar Pandey, Naveen Kumar, Nuzhat Perween, Rajiv Ranjan .. "A Comparative Study of Efficacy of Atorvastatin and Atorvastatin with Omega-3 Fatty Acids Combination in Dyslipidemic Patients". European Journal of Molecular & Clinical Medicine, 10, 2, 2023, 1542-1547.
(2023). 'A Comparative Study of Efficacy of Atorvastatin and Atorvastatin with Omega-3 Fatty Acids Combination in Dyslipidemic Patients', European Journal of Molecular & Clinical Medicine, 10(2), pp. 1542-1547.
A Comparative Study of Efficacy of Atorvastatin and Atorvastatin with Omega-3 Fatty Acids Combination in Dyslipidemic Patients. European Journal of Molecular & Clinical Medicine, 2023; 10(2): 1542-1547.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 26
  • PDF Download: 25
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus